12/01/2012
Anapharm Europe acquires a new high sensitivity equipment
The new equipment allows the determination of extremely low concentration of compounds such as Fluticasone, Salmeterol, Budesonide, Formoterol, Tiotropium, Ethinyl Estradiol, Paricalcitol, etc. In biological fluids.
As part of its efforts to continue to support drug development of women health and inhaler products, Anapharm Europe has purchased a new equipment targeted for method validation with limits of quantification in the low pg/mL level. The AB SCIEX QTRAP 5500 increases our capabilities for the determination extremely low concentrations of compounds such as Fluticasone, Salmeterol, Budesonide, Formoterol, Tiotropium, Ethinyl Estradiol, Paricalcitol, etc. in biological fluids.
MORE NEWS
Successful WHO Inspection
Anapharm Bioanalytics is proud to announce that it has successfully undergone World Health Organization GCP/GLP compliance inspection at its Barcelona based bioanalytical lab
READ MORECell Lab | Anapharm Bioanalytics expands its laboratory capabilities
We are glad to inform you that a cell lab has recently been built at our facilities in Barcelona. Our brand new cell lab capabilities will enable the development and validation of a variety of assays such as Cell Proliferation, Ligand Stimulated Cell Signalling, Protein Secretion, Reporter Gene, NAbs, etc.
READ MOREAnapharm Bioanalytics Brazilian ANVISA Certificate Renewal
Anapharm Bioanalytics is proud to announce that it has recently (February 20th, 2020) renewed its ANVISA (Brazil) certificate. The renewed certification is valid until February 20th, 2022.
READ MORE